Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity

Saved in:
Bibliographic Details
Published in:Acta ophthalmologica (Oxford, England) England), 2014-09, Vol.92 (6), p.e496-e497
Main Authors: Moran, Sarah, O'Keefe, Michael, Hartnett, Claire, Lanigan, Bernadette, Murphy, John, Donoghue, Veronica
Format: Article
Language:English
Subjects:
Angiogenesis Inhibitors - therapeutic use
Antibodies, Monoclonal, Humanized - therapeutic use
Bevacizumab
Case-Control Studies
Electroretinography
Evoked Potentials, Visual
Humans
Infant
Infant, Newborn
Intravitreal Injections
Laser Coagulation - methods
Lasers, Semiconductor
Magnetic Resonance Imaging
Prospective Studies
Recurrence
Retinopathy of Prematurity - classification
Retinopathy of Prematurity - drug therapy
Retinopathy of Prematurity - surgery
Retinopathy of Prematurity - therapy
Vascular Endothelial Growth Factor A - antagonists & inhibitors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1755-375X
1755-3768
DOI:10.1111/aos.12339